Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Equivalence of Generic Fluticasone/Salmeterol vs ADVAIR DISKUS in Asthma
NCT03676413Phase 3Completed
- Sponsor
- Respirent Pharmaceuticals Co. Ltd.
- Start
- Oct 2018
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate nasal spray, salmeterol in asthma, sponsored by Respirent Pharmaceuticals Co. Ltd.. Started Oct 2018; status: completed.
02
Drugs
fluticasone propionate nasal spraysalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03676413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676413.